Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
Mukaka M. et al, (2023), eBioMedicine, 96, 104805 - 104805
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
Taylor WRJ. et al, (2023), PLOS Neglected Tropical Diseases, 17, e0011522 - e0011522
Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial
Taylor WR. et al, (2023), The Lancet Infectious Diseases, 23, 471 - 483
Treatment outcomes and risk factors of death in childhood tuberculous meningitis in Kandahar, Afghanistan: a prospective observational cohort study.
Rahimi BA. et al, (2022), Transactions of the Royal Society of Tropical Medicine and Hygiene, 116, 1181 - 1190
Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
(2022), New England Journal of Medicine, 387, 282 - 283
A comparative study of the proximity to nomadic travel routes and environmental factors on the occurrence of cutaneous leishmaniasis in Kohgiluyeh and Boyer-Ahmad province, southwestern Iran.
Ghatee MA. et al, (2022), Transboundary and emerging diseases, 69, e547 - e553
A family cluster of cutaneous Leishmania major infection unresponsive to intralesional meglumine antimonial: Case reports.
Ziaee M. et al, (2022), Indian journal of medical microbiology, 40, 451 - 454
Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
Taylor WRJ. et al, (2022), The New England journal of medicine, 387
Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data
Mansoor R. et al, (2022), BMC Medicine, 20
Concomitant intramyocardial and hepatic hydatid cysts diagnosed by multi-modality imaging: A rare case report.
Nguyen HTT. et al, (2022), Frontiers in cardiovascular medicine, 9
Outcome of acute bacterial meningitis among children in Kandahar, Afghanistan: A prospective observational cohort study.
Rahimi BA. et al, (2022), PloS one, 17
Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
Taylor WR. et al, (2021), Malaria Journal, 20
Arterolane–piperaquine–mefloquine versus arterolane–piperaquine and artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial
Hamaluba M. et al, (2021), The Lancet Infectious Diseases, 21, 1395 - 1406
The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis
Chan XHS. et al, (2021), PLOS Medicine, 18, e1003766 - e1003766
Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
Taylor WRJ. et al, (2021), PLoS neglected tropical diseases, 15
Development of Weight and Age-based Dosing of Daily Primaquine for Radical Cure of Vivax Malaria
Taylor WR. et al, (2021)
Phylogenetic analysis of Trichostrongylus vitrinus isolates from southwest Iran.
Ghatee MA. et al, (2020), Parasites & vectors, 13
Environmental, climatic and host population risk factors of human cystic echinococcosis in southwest of Iran.
Ghatee MA. et al, (2020), BMC public health, 20
Primaquine for Plasmodium vivax malaria treatment – Authors' reply
Price RN. et al, (2020), The Lancet, 395, 1972 - 1972
Significant Efficacy of a Single Low Dose of Primaquine Compared to Stand-Alone Artemisinin Combination Therapy in Reducing Gametocyte Carriage in Cambodian Patients with Uncomplicated Multidrug-Resistant Plasmodium falciparum Malaria.
Vantaux A. et al, (2020), Antimicrobial agents and chemotherapy, 64, e02108 - e02119